Patient Enrollment in Clinical Trials in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Patient Enrollment in Clinical Trials in Mexico

Patient Enrollment in Clinical Trials in Mexico – Full Service CRO

Patient enrollment is a crucial stage in the process of conducting clinical trials, as it determines the success and efficiency of the study. In recent years, Mexico has emerged as a prominent destination for clinical research, offering a diverse patient population, skilled investigators, and favorable regulatory frameworks.

This blog explores the landscape of patient enrollment in clinical trials in Mexico, highlighting advancements, challenges, and potential solutions.

Advancements in Patient Enrollment

Mexico has made significant strides in improving patient enrollment in clinical trials. The country has a large and diverse population, encompassing various ethnicities, age groups, and health conditions. This diversity is advantageous for conducting trials that require a representative sample of the population.

Additionally, Mexico has well-established research centers and hospitals with experienced investigators, ensuring high-quality data collection and patient care during trials.

Furthermore, Mexico’s regulatory environment has evolved to facilitate patient enrollment. Regulatory bodies such as the Federal Commission for Protection against Sanitary Risks (COFEPRIS) have streamlined approval processes, reducing bureaucratic hurdles and expediting trial initiation.

This enables sponsors and researchers to swiftly initiate clinical trials, thus accelerating patient enrollment.

Challenges in Patient Enrollment

Despite the advancements, Mexico still faces several challenges in patient enrollment for clinical trials. One significant obstacle is the lack of awareness and understanding among the general population about clinical research.

Many potential participants are unaware of the benefits of participating in trials, leading to low recruitment rates. Overcoming this challenge requires targeted educational campaigns to inform the public about the importance and potential impact of clinical trials on healthcare advancements.

Language and cultural barriers also hinder patient enrollment. Although Mexico is a Spanish-speaking country, there are diverse indigenous populations with distinct languages and cultural practices. It is crucial to address these differences through culturally sensitive recruitment strategies and the provision of translated study materials.

Socioeconomic factors can also affect patient enrollment. Limited access to healthcare facilities, financial constraints, and transportation issues can discourage individuals from participating in clinical trials. Collaborations between trial sponsors, research institutions, and local communities can help bridge these gaps by providing logistical support and addressing the financial aspects associated with trial participation.

Patient Enrollment in Clinical Trials in Mexico

Patient Enrollment in Clinical Trials in Mexico

Patient Enrollment in Clinical Trials in Mexico

Potential Solutions and Future Outlook

To enhance patient enrollment in clinical trials, various solutions can be implemented. First, increasing collaboration between academic institutions, hospitals, and pharmaceutical companies can help streamline the recruitment process. Sharing databases and establishing networks can expedite patient identification and enrollment.

Second, targeted recruitment strategies should be developed, focusing on educating healthcare providers about ongoing trials and involving them in the referral process. Engaging with patient advocacy groups and community leaders can also help raise awareness and improve trust in clinical research.

Moreover, digital technologies can play a significant role in patient enrollment. Online platforms, social media campaigns, and telemedicine initiatives can reach a wider audience, making it easier for potential participants to access trial information and communicate with research teams.

In the future, Mexico’s regulatory bodies can continue refining their processes to further streamline trial approval and facilitate patient enrollment. Additionally, fostering international collaborations can provide access to a broader range of clinical trials, thereby attracting more participants and expanding Mexico’s contribution to medical research.


Patient enrollment in clinical trials in Mexico has witnessed remarkable advancements, driven by a diverse patient population, experienced investigators, and supportive regulatory frameworks. However, challenges such as limited awareness, language barriers, and socioeconomic factors continue to impact enrollment rates.

By implementing targeted strategies, improving access to healthcare, and utilizing digital technologies, Mexico can overcome these challenges and enhance patient recruitment for clinical trials. The collective efforts of stakeholders, including researchers, sponsors, healthcare providers, and the government, will play a crucial role in further developing Mexico as a leading destination for clinical research and advancing medical knowledge for the benefit of patients worldwide.

Patient Enrollment in Clinical Trials in Mexico

Source: Roche

Patient Enrollment in Clinical Trials in Mexico

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Patient Enrollment in Clinical Trials in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Patient Enrollment in Clinical Trials in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Patient Enrollment in Clinical Trials in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Patient Enrollment in Clinical Trials in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Patient Enrollment in Clinical Trials in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Patient Enrollment in Clinical Trials in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Patient Enrollment in Clinical Trials in Mexico

The Cohortias Team

Patient Enrollment in Clinical Trials in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Patient Enrollment in Clinical Trials in Mexico

Network & Partnerships